戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 140 every other week for 2 doses by means of subcutaneous infusion.
2 day) or placebo for 24 weeks as a continuous subcutaneous infusion.
3 113 (5 mg/kg, i.p., n=23) followed by a 24-h subcutaneous infusion (1.5 mg kg-1 h-1) by means of a mi
4 ternate routes such as rectal suppositories, subcutaneous infusions, and orally dissolvable tablets s
5                         Likewise, continuous subcutaneous infusion at low (8 microg/h) or high (32 mi
6 te the same pair of compounds via continuous subcutaneous infusion from Alzet miniosmotic pumps.
7 n, a new route of bortezomib administration, subcutaneous infusion, has recently been approved.
8 dy-state conditions after 24 h of continuous subcutaneous infusion in Slco1b2(-/-) mice.
9 n analog treprostinil is also efficacious by subcutaneous infusion, is easier to administer, and has
10 ncurrent oral administration of NPS 2143 and subcutaneous infusion of 17beta-estradiol also resulted
11 hnique of tumescent liposuction involves the subcutaneous infusion of a solution containing lidocaine
12 atment of rats for 10 days with a continuous subcutaneous infusion of aldosterone also increased TSC
13 hanical stimulation in vivo before and after subcutaneous infusion of an 'inflammatory soup' (IS) wer
14                      We have shown here that subcutaneous infusion of Ang II, a vasopressor known to
15 ceptor antagonism, we examined the effect of subcutaneous infusion of candesartan, a non-competitive
16 corticoid therapy replaced with a continuous subcutaneous infusion of cortisol programmed to produce
17 murine cardiac injury model was performed by subcutaneous infusion of either saline or Angiotensin II
18                       Here, a 5-day constant subcutaneous infusion of hIL-6 before portal vein insuli
19  C57BL/6 mice were treated with a continuous subcutaneous infusion of IL-2 (1 x 10(4) IU/d) plus a da
20             Here, it is shown that prolonged subcutaneous infusion of low doses of peptide by means o
21                 Thus, in most cases, chronic subcutaneous infusion of low doses of rotenone does not
22 om male rats and maintained under continuous subcutaneous infusion of obestatin.
23  studies, we showed that a 14-day continuous subcutaneous infusion of recombinant human interleukin (
24  other group (STZ + Lep) (n = 15) received a subcutaneous infusion of recombinant rat leptin (100 mic
25                    Continuous intravenous or subcutaneous infusion of the peptide reduced the glucose
26                        Mice received monthly subcutaneous infusions of cytokines while also being ass
27               FGF21-KO mice given continuous subcutaneous infusions of FGF21 for 4 weeks while on an
28 r day, or placebo administered by continuous subcutaneous infusion over 24 weeks.
29 e observed with both routes of infusion, the subcutaneous infusion produced a much greater lymphocyto
30 tion, and delivered with a Medtronic MiniMed subcutaneous infusion pump.
31 4 200 microgram/kg/d, as a continuous 14-day subcutaneous infusion, suppressed the appearance of circ
32                         JB3 was delivered by subcutaneous infusion using an osmotic minipump implante
33 ed with recombinant methionine murine leptin subcutaneous infusion with osmotic pumps for 12-14 days

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。